By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cytokinetics, Inc. 

280 East Grand Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-624-3000 Fax: 650-624-3010


Drug Discovery

Company News
Cytokinetics, Inc. (CYTK) Announces Completion Of Enrollment In COSMIC-HF 3/13/2015 7:08:21 AM
Cytokinetics, Inc. (CYTK) Joins Global Movement To Raise Awareness For Rare Diseases 3/2/2015 12:27:46 PM
Cytokinetics, Inc. (CYTK) Announces Publication Of Preclinical Data Relating To CK-2127107 And Exercise Tolerance In Rodent Model Of Heart Failure 2/26/2015 9:04:23 AM
Cytokinetics, Inc. (CYTK) To Announce Fourth Quarter Results On February 12, 2015 1/30/2015 9:17:46 AM
SSF's Cytokinetics, Inc. (CYTK) Snags $675 Million+ Deal With Astellas Pharma Inc. (ALPMY) 12/23/2014 6:21:33 AM
Cytokinetics, Inc. (CYTK) Announces Presentations Relating To Tirasemtiv And Effects On Respiratory Muscle Function At International Symposium On ALS/MND 12/8/2014 12:24:04 PM
Cytokinetics, Inc. (CYTK)' President & CEO Robert Blum Receives 2014 Lou Gehrig Iron Horse Award From ALS Therapy Development Institute 11/10/2014 10:31:02 AM
Cytokinetics, Inc. (CYTK) Provides Development Program Update For Omecamtiv Mecarbil 10/27/2014 9:52:45 AM
Despite Conflicting Data, Cytokinetics, Inc. (CYTK) Plans To Take ALS Drug Into Late Stage Study 10/20/2014 11:21:03 AM
Cytokinetics, Inc. (CYTK) Announces Development Program Update For CK-2127107 10/13/2014 10:15:41 AM